Print this page

GEM Hemochron 100 Hits 1,000 Installations Worldwide

Werfen has hit a major milestone with more than 1,000 GEM Hemochron 100 whole blood hemostasis systems placed in hospitals around the world.

First released in select EU countries in 2021, followed by launch in the US in 2022, the GEM Hemochron 100 system is now available globally. 

As the newest member of our legendary Hemochron family, the GEM Hemochron 100 delivers fast and reliable ACT results during cardiovascular procedures. With its cartridge-based, handheld technology, intuitive user interface, and advanced wireless connectivity, the system simplifies testing, improves workflow, and help enhance patient care. 

Congratulations to all those contributing to the success of GEM Hemochron 100 systems—from R&D, Manufacturing, Finance, Marketing, Sales and Service—leading to the achievement of this exciting milestone!

EEMEA ACDx team

Last modified on Wednesday, 06 December 2023 14:02